Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
-
Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
-
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
Bitcoin Bancorp Reports Second Quarter Revenue and Raises Full-Year 2026 Revenue Outlook
-
Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)
-
Integrated Strategic Partners Announces Four New Senior Consultants
-
F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings
-
KANZHUN LIMITED Announces Change of Directors’ Executive Positions
-
USBC Expands Leadership Team with Former JPMorgan Chase and Coinbase Product Executive
-
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Cong
-
Telesat Government Solutions and Cailabs Collaborate on Secure Optical Connectivity for Government Missions
-
COMSTOCK ANNOUNCES $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR AND $450 MILLION DRILLING JOINT VENTURE WITH JERRY JONES
-
Streamex Corp. Appoints Laura Kiernan as Head of Investor Relations
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ardelyx to Participate in Upcoming Investor Conferences
-
Vera Therapeutics to Participate at Upcoming Investor Conferences
-
Pyxis Oncology to Participate in Upcoming Investor Conferences
-
BridgeBio to Participate in September Investor Conferences
-
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
-
Kura Oncology to Participate in Three Investor Conferences in September
-
Descartes Acquires Extensiv
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Outfit7 Expands Talking Tom Heroes: Suddenly Super Through Major Multi-Territory Partnership with Amazon Kids+
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Transaction in Own Shares
-
MAXIMA LT, UAB Board to Change
-
Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
Loblaw to invest approximately $1.2 billion in capital expenditures through remainder of 2026, opening more hard discount stores to help lower prices for more Canadians
-
Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
-
2 Trillion Tokens in 7 Days: B.AI Sparking Developer Frenzy With Accessible Compute
-
Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY
-
Talisker Intersects 111.00 g/t Au over 0.6 m within 30.83 g/t Au over 2.35 metres, from the 2026 Bralorne Gold Project Resource Conversion Program
-
Aben Gold Provides Drill Program Update at Justin Gold-Tungsten Project
-
Lightbridge Receives Notice of Allowance on New Japanese Patent Covering Multi-Zone Fuel Element and 3D Printing Method
-
Vior Gold Corporation Continues to Extend High-Grade Footprint at Ligneris
-
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
-
Remix Therapeutics to Participate in Upcoming Investor Conferences
-
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses
-
Jade Biosciences to Participate in Upcoming Conferences
-
Immunocore to present at upcoming investor conferences
-
AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer
-
NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier
-
Aya Gold & Silver to Acquire Copper-Silver Portfolio
-
Electra Strengthens Commercial Team with Appointment of Veteran Cobalt and Nickel Trader Douglas Geniti
-
VR Releases AGM Results and Provides Update on Empire Transaction
-
Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences
-
eSUN Marks 24th Anniversary With Website Upgrade and September 3D Printing Sale
-
Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP
-
BioCryst to Present at Upcoming Investor Conference
